Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Introduction

Source: Anticipating Resistance in HABP/VABP: Strategies to Improve Empiric Regimens in the ICU

Marion Elligsen, BScPhm, MSc, RPh, ACPR

Keith S. Kaye, MD, MPH

Andrew Shorr, MD, MPH, MBA

Released: November 16, 2022

PreviousNext

Information on this Educational Activity

Faculty

Marion Elligsen, BScPhm, MSc, RPh, ACPR

Practice-Based Researcher
Sunnybrook Research Institute
Antimicrobial Stewardship Pharmacy Lead
Department of Pharmacy
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

Marion Elligsen, BScPhm, MSc, RPh, ACPR, has no relevant financial relationships to disclose.

Keith S. Kaye, MD, MPH

Chief
Division of Allergy, Immunology and Infectious Diseases
Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey

Keith S. Kaye, MD, MPH: consultant/advisor/speaker: Actavis, Allecra, Bayer, Carb-X, Cipla, Clarametyx, ContraFect, Cubist, Entasis, GlaxoSmithKline, Integrated Operations, Melinta, Merck, MicuRx, Nabriva, NS Nanotech, Pratek, Qpex, Shionogi, Spero, Utility, Venatorx, Xellia.

Andrew Shorr, MD, MPH, MBA

Director, Pulmonary and Critical Care Medicine
Washington, DC

Andrew Shorr, MD, MPH, MBA: consultant/advisor/speaker: Merck, Pfizer,Shionogi.